Avacta Group Plc - notizie pubblicate 142 - letture 4.950


Avacta Group plc

AVACTA GROUP PLC

Investor Webinar

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...

28.03.2024
Avacta Group plc

AVACTA GROUP PLC

Research and Development Spotlight Series – Episode 1

In the new research and development spotlight series we will take you a little deeper into the science behind the avacta therapeutics pipeline. in the first episode today we're goi ...

27.03.2024
Avacta Group plc

AVACTA GROUP PLC

Update on AVA6000 Phase 1a Clinical Trial Progress

Three patients now dosed in the us in two-weekly dose escalation study avacta receives approval to enrol patients in the uk in the ongoing two-weekly dose escalation study avacta g ...

21.03.2024
Avacta Group plc

AVACTA GROUP PLC

Result of General Meeting

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...

18.03.2024
Avacta Group plc

AVACTA GROUP PLC

Result of General Meeting

Avacta group plc (aim: avct), a life sciences company developing innovative, targeted oncology drugs and diagnostics, is pleased to announce that the resolution put to shareholders ...

18.03.2024
Avacta Group plc

AVACTA GROUP PLC

Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024

Avacta group plc (aim: avct), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces updated clinical data from the first- ...

06.03.2024
Avacta Group plc

AVACTA GROUP PLC

Result of Placing

Important please select the country in which you are located or resident: your country select afghanistanalbaniaalgeriaamerican samoaandorraangolaanguillaantarcticaantigua and barb ...

29.02.2024
Avacta Group plc

AVACTA GROUP PLC

Proposed REX Retail Offer

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...

28.02.2024
Avacta Group plc

AVACTA GROUP PLC

Proposed Fundraise to progress Therapeutics

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...

28.02.2024
Avacta Group plc

AVACTA GROUP PLC

Proposed REX Retail Offer

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...

28.02.2024
Avacta Group plc

AVACTA GROUP PLC

Proposed Fundraise to progress Therapeutics Division pipeline

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer avacta group plc published this conten ...

28.02.2024
Avacta Group plc

AVACTA GROUP PLC

Issue of Equity and Total Voting Rights

Avacta group plc (aim: avct), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics today announces it has issued and allotted a total of ...

22.01.2024
Avacta Group plc

AVACTA GROUP PLC

Issue of Equity and Total Voting Rights

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer avacta group plc pub ...

22.01.2024
Avacta Group plc

AVACTA GROUP PLC

Appointment of Christina Coughlin, M.D., Ph.D. as Head of Research and Development

Appointment marks the transition from a research organization to a clinical stage biotechnology company avacta group plc (aim: avct), a life sciences company developing innovative, ...

19.01.2024
Avacta Group plc

AVACTA GROUP PLC

Appointment of Chief Business Officer

Appointment signals commercial emphasis for avacta to leverage clinical progress avacta group plc (aim: avct), a life sciences company developing innovative, targeted oncology drug ...

19.12.2023
Condividi